drugset / Trial / NCT00267254

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

NCT00267254 ↗

Phase 3 Completed 640 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of cholesterol medications to see how the different treatments compare to one another.

Timeline

Start
2006-01
Primary completion
—
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — —
Subject Simvastatin Small molecule — —
Subject torcetrapib Small molecule — —

Indications